Should I buy or sell Boston Scientific stock right now?

18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 1 hold rating, 16 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BSX shares. View BSX analyst ratings or view top-rated stocks .

What is Boston Scientific's stock price target for 2024?

18 brokerages have issued twelve-month price targets for Boston Scientific's stock. Their BSX share price targets range from $55.00 to $66.00. On average, they predict the company's share price to reach $61.18 in the next year. This suggests a possible upside of 5.8% from the stock's current price. View analysts price targets for BSX or view top-rated stocks among Wall Street analysts .

How have BSX shares performed in 2023?

Boston Scientific's stock was trading at $46.27 at the start of the year. Since then, BSX stock has increased by 24.9% and is now trading at $57.81. View the best growth stocks for 2023 here .

Are investors shorting Boston Scientific?

Boston Scientific saw a increase in short interest in the month of December. As of December 15th, there was short interest totaling 11,640,000 shares, an increase of 26.0% from the November 30th total of 9,240,000 shares. Based on an average trading volume of 7,400,000 shares, the days-to-cover ratio is presently 1.6 days. View Boston Scientific's Short Interest .

When is Boston Scientific's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 7th 2024. View our BSX earnings forecast .

How were Boston Scientific's earnings last quarter?

Boston Scientific Co. (NYSE:BSX) issued its quarterly earnings results on Thursday, October, 26th. The medical equipment provider reported $0.50 earnings per share for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The medical equipment provider earned $3.53 billion during the quarter, compared to analyst estimates of $3.48 billion. Boston Scientific had a net margin of 8.93% and a trailing twelve-month return on equity of 15.46%. The company's quarterly revenue was up 11.3% compared to the same quarter last year. During the same quarter last year, the business earned $0.43 earnings per share. Read the conference call transcript .

What ETFs hold Boston Scientific's stock?

ETFs with the largest weight of Boston Scientific (NYSE:BSX) stock in their portfolio include Simplify Health Care ETF (PINK) , Goldman Sachs Future Health Care Equity ETF (GDOC) , Fidelity Disruptive Medicine ETF (FMED) , iShares U.S. Medical Devices ETF (IHI) , Global X Aging Population ETF (AGNG) , BlackRock Future Health ETF (BMED) , BNY Mellon Sustainable US Equity ETF (BKUS) and JPMorgan Social Advancement ETF (UPWD) .

What guidance has Boston Scientific issued on next quarter's earnings?

Boston Scientific updated its fourth quarter earnings guidance on Thursday, October, 26th. The company provided earnings per share guidance of $0.49-0.52 for the period, compared to the consensus EPS estimate of $0.52.

What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?

947 employees have rated Boston Scientific Chief Executive Officer Michael F. Mahoney on Glassdoor.com . Michael F. Mahoney has an approval rating of 98% among the company's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Boston Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA) , Alibaba Group (BABA) , Intel (INTC) , AT&T (T) , CVS Health (CVS) , Walt Disney (DIS) , Bank of America (BAC) , Advanced Micro Devices (AMD) , Visa (V) and Salesforce (CRM) .

How do I buy shares of Boston Scientific?

Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Boston Scientific have any subsidiaries?

The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation. Read More

Top-Rated StocksTop-Rated

NYSE:BSX

Boston Scientific (BSX) Stock Price, News & Analysis

$57.81

+1.53 (+2.72%)

(As of 12/29/2023 ET)

Compare

Today's Range: $56.77
▼
$58.34
50-Day Range: $49.53
▼
$57.81
52-Week Range: $44.35
▼
$58.34

Volume: 10.67 million shs
Average Volume: 5.22 million shs
Market Capitalization: $84.69 billion

P/E Ratio: 70.50
Dividend Yield: N/A
Price Target: $61.18

Boston Scientific MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 5.8% Upside
$61.18 Price Target
Short Interest: Healthy
0.79% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -1.02
Upright™ Environmental Score
News Sentiment: 0.63
Based on 25 Articles This Week
Insider Trading: Selling Shares
$12.46 M Sold Last Quarter
Proj. Earnings Growth: 10.95%
From $2.01 to $2.23 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.41 out of 5 stars

Medical Sector

230th out of 950 stocks

Surgical & Medical Instruments Industry

23rd out of 92 stocks

2.5

Analyst's Opinion

Consensus Rating
Boston Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 16 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $61.18, Boston Scientific has a forecasted upside of 5.8% from its current price of $57.81.
Amount of Analyst Coverage
Boston Scientific has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
0.79% of the outstanding shares of Boston Scientific have been sold short.
Short Interest Ratio / Days to Cover
Boston Scientific has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Boston Scientific has recently increased by 25.97%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Boston Scientific does not currently pay a dividend.
Dividend Growth
Boston Scientific does not have a long track record of dividend growth.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Boston Scientific has received a 60.69% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Medical monitors for cardiac surgery", "Surgical instruments for cardiac operations", "Cardiac resynchronization therapy (CRT) devices", "Wound closure devices", "Medical endoscopes", and "Coronary stents" products. See details.
Environmental Sustainability
The Environmental Impact score for Boston Scientific is -1.02.

3.1

News and Social Media Coverage

News Sentiment
Boston Scientific has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 25 news articles for Boston Scientific this week, compared to 21 articles on an average week.
Search Interest
20 people have searched for BSX on MarketBeat in the last 30 days. This is an increase of 54% compared to the previous 30 days.
MarketBeat Follows
12 people have added Boston Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 71% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Boston Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,457,510.00 in company stock.
Percentage Held by Insiders
Only 0.71% of the stock of Boston Scientific is held by insiders.
Percentage Held by Institutions
89.11% of the stock of Boston Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Boston Scientific are expected to grow by 10.95% in the coming year, from $2.01 to $2.23 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Boston Scientific is 70.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 105.36.
Price to Earnings Ratio vs. Sector
The P/E ratio of Boston Scientific is 70.50, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 68.30.
Price to Earnings Growth Ratio
Boston Scientific has a PEG Ratio of 2.30. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Boston Scientific has a P/B Ratio of 4.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Boston Scientific Stock (NYSE:BSX)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

BSX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BSX Stock News Headlines

December 31, 2023 | ca.finance.yahoo.com

BSX Jan 2024 60.000 call

December 31, 2023 | americanbankingnews.com

Boston Scientific (NYSE:BSX) Hits New 12-Month High at $57.65

December 31, 2023 | Behind the Markets (Ad)

FINAL OFFER: $9 for a FULL YEAR of stock picks

We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $9. That's less than a cup of coffee! And what do you get for that $9?

December 30, 2023 | za.investing.com

Pro Research: Wall Street sees bright future for Boston Scientific

December 30, 2023 | americanbankingnews.com

Boston Scientific (NYSE:BSX) Given "Overweight" Rating at Wells Fargo & Company

December 30, 2023 | americanbankingnews.com

Boston Scientific's (BSX) Buy Rating Reaffirmed at BTIG Research

December 29, 2023 | markets.businessinsider.com

Buy Rating on Boston Scientific Amid Anticipated Early FDA Approval and Positive Farapulse Study Outcomes

December 29, 2023 | cnbc.com

Stocks making the biggest moves midday: Fisker, Lyft, Boston Scientific and more

December 31, 2023 | MarketBeat Internal (Ad)

New Year's Sale: Get MarketBeat All Access Free For 30 Days

Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscription

December 29, 2023 | finance.yahoo.com

BSX Dec 2023 55.500 call

December 29, 2023 | msn.com

Midday Movers: Boston Scientific Heart System, Tesla Cybertruck Accident

December 29, 2023 | markets.businessinsider.com

Boston Scientific Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)

December 29, 2023 | finance.yahoo.com

These Two Stocks Rocked During 2023 And Are Stretching To New Highs

December 29, 2023 | realmoney.thestreet.com

Farapulse approval coming sooner than expected for Boston Scientific, says BTIG

December 29, 2023 | msn.com

Why Medical Devices Behemoth Boston Scientific Shares Are Rising Friday

December 28, 2023 | msn.com

Boston Sci sees Farapulse PFA receiving FDA approval in Q1

December 28, 2023 | finance.yahoo.com

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

December 26, 2023 | za.investing.com

Pro Research: Wall Street eyes Boston Scientific's robust growth

December 26, 2023 | finance.yahoo.com

3 Medical-Device Stocks Could Click in 2024

December 23, 2023 | americanbankingnews.com

Boston Scientific (NYSE:BSX) Price Target Raised to $66.00 at Truist Financial

December 22, 2023 | msn.com

Boston Scientific fined for unpermitted emissions at Maple Grove facility

December 22, 2023 | finance.yahoo.com

Show Me The Money: Inside Ken Griffin's Citadel's Jaw-Dropping $7 Billion Return

December 18, 2023 | finance.yahoo.com

UPDATE 1-Business travel emissions drop as many firms fly less -survey

December 14, 2023 | finance.yahoo.com

Boston Scientific (BSX) Hits 52-Week High: What's Aiding It?

December 13, 2023 | markets.businessinsider.com

What 18 Analyst Ratings Have To Say About Boston Scientific

December 12, 2023 | finance.yahoo.com

Boston Scientific: When a Loved One Has Parkinson’s Disease

December 5, 2023 | finance.yahoo.com

Meet Three Boston Scientific Employees Committed to Protecting People From Stroke

See More Headlines

Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/26/2023
Today: 12/31/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 2/07/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NYSE:BSX
CUSIP: 10113710
CIK: 885725
Web: www.bostonscientific.com
Phone: (508) 683-4000
Fax: 508-683-5675
Employees: 45,000
Year Founded: 1979

Price Target and Rating

Average Stock Price Target: $61.18
High Stock Price Target: $66.00
Low Stock Price Target: $55.00
Potential Upside/Downside: +5.8%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 18 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.82
Trailing P/E Ratio: 70.50
Forward P/E Ratio: 28.76
P/E Growth: 2.3
Net Income: $698 million
Net Margins: 8.93%
Pretax Margin: 13.63%
Return on Equity: 15.46%
Return on Assets: 8.52%

Debt

Debt-to-Equity Ratio: 0.44
Current Ratio: 1.42
Quick Ratio: 0.90

Sales & Book Value

Annual Sales: $12.68 billion
Price / Sales: 6.68
Cash Flow: $2.60 per share
Price / Cash Flow: 22.22
Book Value: $12.27 per share
Price / Book: 4.71

Miscellaneous

Outstanding Shares: 1,464,980,000
Free Float: 1,454,582,000
Market Cap: $84.69 billion
Optionable: Optionable
Beta: 0.78

Social Links

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Michael F. Mahoney (Age 58)
Chairman, President & CEO
Comp: $3.77M
Mr. David J. Roux (Age 66)
Independent Director
Comp: $135k
Mr. Daniel J. Brennan (Age 57)
Executive VP & CFO
Comp: $1.69M
Mr. Joseph M. Fitzgerald (Age 59)
Executive VP & Group President of Cardiology
Comp: $1.53M
Mr. Jeffrey B. Mirviss (Age 57)
Executive VP & President of Peripheral Interventions
Comp: $1.15M
Mr. Arthur Crosswell Butcher (Age 52)
Executive VP and Group President of MedSurg & Asia Pacific
Comp: $1.4M
Mr. John Bradley Sorenson (Age 55)
Executive Vice President of Global Operations
Mr. Jonathan R Monson
Senior VP, Global Controller & Chief Accounting Officer
Ms. Jodi Euerle Eddy (Age 50)
Senior VP and Chief Information & Digital Officer
Ms. Susan Vissers Lisa (Age 54)
Vice President of Investor Relations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

BSX Stock Analysis - Frequently Asked Questions

Should I buy or sell Boston Scientific stock right now?: 18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 1 hold rating, 16 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BSX shares.
View BSX analyst ratings or view top-rated stocks.
What is Boston Scientific's stock price target for 2024?: 18 brokerages have issued twelve-month price targets for Boston Scientific's stock. Their BSX share price targets range from $55.00 to $66.00. On average, they predict the company's share price to reach $61.18 in the next year. This suggests a possible upside of 5.8% from the stock's current price.
View analysts price targets for BSX or view top-rated stocks among Wall Street analysts.
How have BSX shares performed in 2023?: Boston Scientific's stock was trading at $46.27 at the start of the year. Since then, BSX stock has increased by 24.9% and is now trading at $57.81.
View the best growth stocks for 2023 here.
Are investors shorting Boston Scientific?: Boston Scientific saw a increase in short interest in the month of December. As of December 15th, there was short interest totaling 11,640,000 shares, an increase of 26.0% from the November 30th total of 9,240,000 shares. Based on an average trading volume of 7,400,000 shares, the days-to-cover ratio is presently 1.6 days.
View Boston Scientific's Short Interest.
When is Boston Scientific's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 7th 2024.
View our BSX earnings forecast.
How were Boston Scientific's earnings last quarter?: Boston Scientific Co. (NYSE:BSX) issued its quarterly earnings results on Thursday, October, 26th. The medical equipment provider reported $0.50 earnings per share for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The medical equipment provider earned $3.53 billion during the quarter, compared to analyst estimates of $3.48 billion. Boston Scientific had a net margin of 8.93% and a trailing twelve-month return on equity of 15.46%. The company's quarterly revenue was up 11.3% compared to the same quarter last year. During the same quarter last year, the business earned $0.43 earnings per share.
Read the conference call transcript.

What ETFs hold Boston Scientific's stock?: ETFs with the largest weight of Boston Scientific (NYSE:BSX) stock in their portfolio include Simplify Health Care ETF (PINK), Goldman Sachs Future Health Care Equity ETF (GDOC), Fidelity Disruptive Medicine ETF (FMED), iShares U.S. Medical Devices ETF (IHI), Global X Aging Population ETF (AGNG), BlackRock Future Health ETF (BMED), BNY Mellon Sustainable US Equity ETF (BKUS) and JPMorgan Social Advancement ETF (UPWD).
What guidance has Boston Scientific issued on next quarter's earnings?: Boston Scientific updated its fourth quarter earnings guidance on Thursday, October, 26th. The company provided earnings per share guidance of $0.49-0.52 for the period, compared to the consensus EPS estimate of $0.52.
What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?: 947 employees have rated Boston Scientific Chief Executive Officer Michael F. Mahoney on Glassdoor.com. Michael F. Mahoney has an approval rating of 98% among the company's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Boston Scientific own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and Salesforce (CRM).
How do I buy shares of Boston Scientific?: Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Boston Scientific have any subsidiaries?: The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation.
Read More

This page (NYSE:BSX) was last updated on 12/31/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial